ADCT - ADC Therapeutics rises on $60M PIPE financing
2025-10-13 07:50:48 ET
More on ADC Therapeutics
- ADC Therapeutics SA 2025 Q2 - Results - Earnings Call Presentation
- ADC Therapeutics SA (ADCT) Q2 2025 Earnings Call Transcript
- ADC Therapeutics targets $600M–$1B peak revenue potential for ZYNLONTA amid strategic refocus and cost cuts
- Seeking Alpha’s Quant Rating on ADC Therapeutics
- Historical earnings data for ADC Therapeutics